EarCentric EasyCharge vs Signia Pure C&G IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

EarCentric EasyCharge
The EarCentric EasyCharge is a budget-priced prescription behind-the-ear hearing aid released in 2023, earning a C grade with a SoundScore of 2.7/5 in our lab testing. At $229, it sits at the entry level of the prescription hearing aid market. In our standardized testing, this device showed a significant performance gap compared to the prescription hearing aid category. Speech clarity scores were notably low, measuring 2.32 points below the category average in quiet environments and 0.96 points below average in noisy settings. Music streaming performance was similarly limited at 0.0/5, falling 2.64 points below average. Own-voice comfort scored 1.9/5, which is 0.85 points below the category norm. The EasyCharge's standout feature is its excellent feedback handling, scoring a perfect 5.0/5—0.29 points above the category average of 4.71. This means users are unlikely to experience whistling or squealing during everyday use. The device also offers convenient rechargeable batteries. Within the same budget price range, the RxEars Rxi achieves significantly stronger overall performance with a 4.09/5 SoundScore. Consumers prioritizing sound quality on a tight budget may find better value elsewhere, though the EasyCharge's feedback stability and rechargeable design could appeal to users with modest amplification needs who value convenience over maximum speech clarity.
Choice

Signia Pure C&G IX
The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Audio scenes
Using MUSHRA scenes (Tuned)
Fitting configuration for tuned fit